News and Trends 23 Jun 2022
Gemelli Biotech to work on gastrointestinal diseases with new $19M funding
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed a $19 million series A…